Expression of epidermal growth factor in gestational trophoblastic disease (GTD)

Journal of Experimental and Clinical Cancer Research

Volumn 16, Issue 2, 1997, Pages 129-134

  John, M ^a   Rajalekshmy, T N ^b   Nair, M B ^c   Augustine, J ^d   Schultz, G ^e   Nair, M K ^a   Balaram, P ^a  

^a REGIONAL CANCER CENTRE   (India)

^b SAT Hospital   (India)

^c DDRC   (India)

^d GOVERNMENT MEDICAL COLLEGE   (India)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

EGF; Gestational trophoblastic disease; Placenta

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLACENTA; PRIORITY JOURNAL; TROPHOBLASTIC DISEASE;

ADOLESCENT; ADULT; CHORIOCARCINOMA; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; HYDATIDIFORM MOLE; HYDATIDIFORM MOLE, INVASIVE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PLACENTA; PREGNANCY; REFERENCE VALUES; UTERINE NEOPLASMS;

EID: 0030929244     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. John M., Balaram P., Rajakekshmy T.N., et al.: Profile of Gestational Trophoblastic Disease in Kerala, India. Med. Sci. Res. 21:431-432, 1993.
2. Muhlhauser J., Crescimanno C., Kaufmann P. et al.: Differentiation and proliferation patterns in human trophoblast revealed by c-erb-2 oncogene product and EGFR. J. Histochem. Cytochem. 41: 165-173, 1993.
3. Chao H.H., Yang V.C., and Chen J.K.: Acidic FGF and EGF are involved in the autocrine growth stimulation of a human nasopharyngeal carcinoma cell line and sub-line cells. Int. J. Cancer. 53:807-812, 1993.
4. Engebraaten O., Bjerkvig R., Pedersen P.H., et al.: Effects of EGF, bFGF, NGF and PDGF on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int. J. Cancer. 53: 209-214, 1993.
5. Mukaida H., Toi M., Hirai Y., et al.: Clinical significance of the expression of Epidermal Growth Factor and its receptor in esophageal cancer. Cancer. 68: 142-148, 1991.
6. Ladines-Llave C., Maruo T., Manalo A.S. et al.: Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy. Am. J. Obstet. Gynecol. 165: 1377-1382, 1991.
7. Evain-Brion D., Alsat E.: Epidermal growth factor receptor and human foetoplacental development. Jounral of Pediatric Endocrinology. 7: 295-302, 1994.
8. Haimovici F. and Anderson D.J.: Effects of Growth Factors and Growth Factor Extracellular Matrix Interactions on Mouse Trophoblast Outgrowth In Vitro. Biology of Reproduction. 49: 124-130, 1993.
9. Bass K.E., Morrish D., Roth I., et al.: Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine fators modify this process. Developmental Biology. 164: 550-61, 1994.
10. Roberts A.B., Anzano M.A., Lamb L.C., et al.: Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature (Lond), 331: 173-175, 1988.
11. Bigner S.H., Humphrey D.A., Wong A.J., et al.: Characterization of the epidermal-growth-factor receptor in human glioma cell line and xenografts. Cancer Res. 50:8017-8022, 1990.
12. Ekstrand A.J., James C.D., Cavenee W.K., et al.: Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51: 3753-3761, 1991.
13. Morrow C.P., Kletzky O.A., DiSaia P.J., et al.: Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am. J. Obstet. Gynecol. 128: 424-428, 1977.
14. Hatch K.D., Shingleton H.M., Austin J.M.: Southern Regional Trophoblastic Disease Centre. South Med. J. 71: 1334-1339, 1978.
15. WHO Scientific Group. Gestational Trophoblastic Diseases. Technical Report Series 692, 1983.
16. Bisonnette F., Cook C., Geoghegan T., et al.: Transforming growth factor-α and epidermal growth factor messenger ribonucleic acid and protein levels in human placentas from early., mid., and late gestation. Am. J. Obstet. Gynecol. 166: 192-199, 1992.
17. Parrazini F., Mangili G., Belloni C., et al.: The problem of identification of prognostic factors for persistent trophoblastic disease. Gynecol. Oncol. 30: 57-62, 1988.
18. Ladines-Llave C.A., Maruo T., Manalo A.M., et al.: Decreased expression of epidermal growth factor and its receptor in the malignant transofrmation of trophoblasts. Cancer. 71: 4118-23, 1993.
19. Sibilia M., Wagner E.F.: Strain dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234-238, 1995.
20. Sinsbury J.R.;C., Fandon J.R., Needham G.K., et al.: Epidermal Growth Factor Receptor status as predictor of early recurrence of a death from breast cancer. Lancet. 1: 1398-1402, 1987.
21. Fox S.B., Smith K., Hollyer J., et al.: The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat. 29: 41-49, 1994.
22. Klijn J.G.M., Berns P.M.J.J., Schmitz P.I.M., et al.: The clinical significance of epidermal growth factor receptor in human breast cancer: review of 5232 patients. Endocrine Rev. 13: 21-27, 1992.
23. Smith K., Fennelly J.A., Neal D.E., et al.: Characterisation and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumours. Cancer Res. 49: 5810-5818, 1989.